News
3h
Investor's Business Daily on MSNStock Market Today: Indexes Negative As Stocks Gyrate; Investors Unsteady As Tariffs Set To Begin (Live Coverage)A relief rally for stocks failed miserably Tuesday, with massive gains for the major indexes morphing into sizable losses as ...
6d
ABP News on MSNGut Health Becomes A Priority With The Rise Of Probiotic DietsProbiotics play a crucial role in maintaining gut health, boosting immunity, and aiding digestion. Discover their benefits, ...
6d
Health on MSNShould You Take Turmeric and Probiotics Together?Probiotics and turmeric are dietary supplements used for many health conditions. When taken together, they may improve gut ...
Gateshead's Keiran White wants to change the narrative around stomas - and said getting surgery had completely revolutionised ...
A live webcast of the 24 th Annual Needham Virtual Healthcare Conference presentation will be available on the Events and Presentations section of the Company’s website. A replay of the webcast will ...
Objective In utero exposure to maternal inflammation may impact immune system development and subsequent risk of disease. We investigated whether a maternal diagnosis of IBD before childbirth is ...
Tiny bacterial vesicles from probiotics may provide a safer way to treat gut inflammation. Could this be the next big thing ...
20h
India Today on MSNIs your vitamin D low? Your gut might be paying the priceThat post-lunch bloat, those unpredictable bathroom visits, and even chronic conditions like IBS or IBD could be tied to that sunshine vitamin you’ve been neglecting.
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic ...
However uncomfortable or embarrassing they may be, farts are natural – in fact, they are a sign that your digestive system is alive. Quite literally, actually.
The high value attached by pharma companies to inflammation and immunology (I&I) programmes is on display once again, as AbbVie agrees a deal worth up to $1.7 billion for an inflammatory bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results